(19)
(11) EP 1 408 043 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION

(48) Corrigendum issued on:
16.06.2004 Bulletin 2004/25

(43) Date of publication:
14.04.2004 Bulletin 2004/16

(21) Application number: 02447192.2

(22) Date of filing: 09.10.2002
(51) International Patent Classification (IPC)7C07D 513/20, A61K 31/429, A61P 35/00, C07F 7/18
// (C07D513/20, 319:00, 311:00, 277:00)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: Unibioscreen S.A.
1070 Bruxelles (BE)

(72) Inventors:
  • van Quaquebeke, Eric
    1200 Woluwe-Saint-Lambert (BE)
  • Braekman, Jean-Claude
    B-1640 Rhode-Saint-Genese (BE)
  • Simon, Gentiane
    1070 Bruxelles (BE)
  • Guissou, Pierre
    Ouagadougou (BF)
  • Nacoulma, Odile Germaine
    Ouagadougou (BF)
  • Dewelle, Janique
    6238 Luttre (BE)
  • Darro, Francis
    1180 Uccle (BE)
  • Kiss, Robert
    1600 Sint-Pieters-Leeuw (BE)

(74) Representative: Brants, Johan Philippe Emile et al
De Clercq, Brants & Partners cv Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

 
Remarks:
Claims 11-21 are deemed to be abandoned due to non-payment of the claims fees (Rule 31 (2) EPC).
 


(54) 2''oxo-voruscharin and analogues thereof


(57) The present invention relates to the novel compound 2" oxo-voruscharin and analogues. In addition, the present invention relates to pharmaceutical compositions comprising the novel 2" oxo-voruscharin or analogues. The present invention further relates to the 2" oxo-voruscharin and analogues for use as a medicament and for use in the preparation of a medicament for treating cancer. The present invention also relates to a method of treating cancer.